Compounds and methods for the inhibition of the expression of VCAM-1

Details for Australian Patent Application No. 2002300328 (hide)

International Classifications

Event Publications

19 December 2002 Application Open to Public Inspection

Published as AU-B-2002300328

8 January 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This application lapsed under section 142(2)(d). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

11 March 2004 Section 223 Application Received

AtheroGenics, Inc An application to extend the time from 14 May 2003 to 14 Feb 2004 in which to pay a renewal fee has been filed . Address for service in Australia - Blake Dawson Waldron Level 39 101 Collins Street Melbourne VIC 3000

29 April 2004 Section 223 Application Allowed

AtheroGenics, Inc The time in which to pay a renewal fee has been extended to 14 Feb 2004. Address for service in Australia - Blake Dawson Waldron Level 39 101 Collins Street Melbourne VIC 3000

13 April 2006 Application Accepted

Published as AU-B-2002300328

10 August 2006 Standard Patent Sealed

9 December 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.